Related references
Note: Only part of the references are listed.Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier et al.
NATURE COMMUNICATIONS (2021)
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Denis L. Jardim et al.
CANCER CELL (2021)
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
James G. Nicholson et al.
CANCER DISCOVERY (2021)
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing
Scott Newman et al.
CANCER DISCOVERY (2021)
Report of Canonical BCR-ABL1 Fusion in Glioblastoma
Ying Pang et al.
JCO PRECISION ONCOLOGY (2021)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No
V. Prasad et al.
ANNALS OF ONCOLOGY (2020)
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
Nitin Roper et al.
CELL REPORTS MEDICINE (2020)
Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
Jun Su et al.
FRONTIERS IN GENETICS (2019)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Christopher Cunniff et al.
MOLECULAR SYNDROMOLOGY (2017)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
Wendy Chang et al.
CLINICAL CANCER RESEARCH (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Kasmintan A. Schrader et al.
JAMA ONCOLOGY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
IDH Mutation in Glioma: New Insights and Promises for the Future
Zorbey Turkalp et al.
JAMA NEUROLOGY (2014)
LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma
Jacky T. Yeung et al.
CLINICAL CANCER RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil
Carlos E. Pitroski et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
Matthias Mehling et al.
ACTA NEUROPATHOLOGICA (2007)
Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations
Richard H. Scott et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors
A Facoetti et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
